Clinical Trial Update: t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection [Phase 2]

View source ↗

Summary

Phase 2 trial investigating t-PA prophylaxis to prevent catheter-associated thrombosis and infection; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Venous Catheter Thrombosis
• Central Venous Catheter-associated Bloodstream Infection

Drugs mentioned

• t-PA (tissue plasminogen activator)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Central Venous Catheter Thrombosis, Central Venous Catheter Associated Bloodstream Infection | Phase 2 | Status: COMPLETED | Results posted: 2021-07-13